Important Notice of Announcement to shareholder of Xtrackers (IE) plc
Xtrackers (IE) plc
Investment Company with Variable Capital
Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland
Registration number: 393802
(the “Company”)
Important Notice to Shareholders of
Xtrackers MSCI Japan ESG Screened UCITS ETF
1D (ISIN: IE00BPVLQD13)
2D – GBP Hedged (ISIN: IE00BPVLQF37)
4C – USD Hedged (ISIN: IE00BTGD1B38)
Xtrackers MSCI AC World ESG Screened UCITS ETF
1C (ISIN: IE00BGHQ0G80)
5C – USD Hedged (ISIN: IE000WGF1X01)
Xtrackers MSCI World ESG Screened UCITS ETF
1D (ISIN: IE00BCHWNQ94)
Xtrackers MSCI USA ESG Screened UCITS ETF
1C (ISIN: IE00BJZ2DC62)
Xtrackers MSCI Innovation UCITS ETF
1C (ISIN: IE0006FFX5U1)
Xtrackers MSCI Fintech Innovation UCITS ETF
1C (ISIN: IE000YDOORK7)
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF
1C (ISIN: IE000KD0BZ68)
Xtrackers MSCI Next Generation Internet Innovation UCITS ETF
1C (ISIN: IE000XOQ9TK4)
(each a “Fund”, together the “Funds”)
3 January 2025
The board of directors of the Company (the "Board of Directors") hereby informs the shareholders of the Funds (the "Shareholders") that MSCI Limited (the “Index Administrator”) informed the Company on 16 December 2024 that it would introduce certain changes (as set out below) to the name of the reference index of each Fund (the “Reference Index”) on 3 February 2025 (the “Effective Date”).
Capitalised terms used in this notice shall have the same meaning ascribed to them in the latest version of the prospectus of the Company (the “Prospectus”) or the supplement of the relevant Fund (the “Supplement”), unless the context otherwise requires.
As of the Effective Date, the relevant Reference Index of each Fund will be renamed as set out below:
Fund |
Current Reference Index Name |
New Reference Index Name |
Xtrackers MSCI Japan ESG Screened UCITS ETF |
MSCI Japan Select ESG Screened Index |
MSCI Japan Select Screened Index |
Xtrackers MSCI AC World ESG Screened UCITS ETF |
MSCI ACWI Select ESG Screened Index |
MSCI ACWI Select Screened Index |
Xtrackers MSCI World ESG Screened UCITS ETF |
MSCI World Select ESG Screened Index |
MSCI World Select Screened Index |
Xtrackers MSCI USA ESG Screened UCITS ETF |
MSCI USA Select ESG Screened Index |
MSCI USA Select Screened Index |
Xtrackers MSCI Innovation UCITS ETF |
MSCI ACWI IMI Innovation Select ESG Screened 200 Index |
MSCI ACWI IMI Innovation Select Screened 200 Index |
Xtrackers MSCI Fintech Innovation UCITS ETF |
MSCI ACWI IMI Fintech Innovation Select ESG Screened 100 Index |
MSCI ACWI IMI Fintech Innovation Select Screened 100 Index |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF |
MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index |
MSCI ACWI IMI Genomic Innovation Select Screened 100 Index |
Xtrackers MSCI Next Generation Internet Innovation UCITS ETF |
MSCI ACWI IMI Next Generation Internet Innovation Select ESG Screened 100 Index |
MSCI ACWI IMI Next Generation Internet Innovation Select Screened 100 Index |
As a result, the Board of Directors has resolved to amend the name of each of the following Funds as set out below on the Effective Date:
Current Fund Name |
New Fund Name |
Xtrackers MSCI Japan ESG Screened UCITS ETF |
Xtrackers MSCI Japan Screened UCITS ETF |
Xtrackers MSCI AC World ESG Screened UCITS ETF |
Xtrackers MSCI AC World Screened UCITS ETF |
Xtrackers MSCI World ESG Screened UCITS ETF |
Xtrackers MSCI World Screened UCITS ETF |
Xtrackers MSCI USA ESG Screened UCITS ETF |
Xtrackers MSCI USA Screened UCITS ETF |
For the avoidance of doubt, the names of the following Funds will remain unchanged:
- Xtrackers MSCI Innovation UCITS ETF
- Xtrackers MSCI Fintech Innovation UCITS ETF
- Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF
- Xtrackers MSCI Next Generation Internet Innovation UCITS ETF
Furthermore, each Fund’s investment objective, investment policy, risk profile and fees will remain unchanged. Each Fund will continue to be subject to the disclosure requirements of a financial product under Article 8(1) of SFDR.
- General Information
Copies of the revised Supplement and the key information document of each Fund reflecting the aforementioned changes will be made available on the website of the Company (www.Xtrackers.com) on or around the Effective Date, and copies thereof may be obtained on request free of charge at the registered office of the Company or at the offices of foreign representatives, once available.
Shareholders who have any queries or to whom any of the above is not clear should seek advice from their stockbroker, bank manager, legal advisor, accountant or other independent financial advisor. Shareholders should also consult their own professional advisors as to the specific tax implications under the laws of the countries of their nationality, residence, domicile or incorporation.
Further information in relation to the changes may be obtained from the legal entities mentioned under Contact information below, the offices of foreign representatives or by sending an email to Xtrackers@dws.com.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Further information in relation to the UK sustainability labelling and disclosure requirements can be found on the UK FCA’s website.
Neither the contents of the Company’s website nor the contents of any other website accessible from hyperlinks on the Company’s website is incorporated into, or forms part of, this announcement.
Yours faithfully,
______________________________
Director
For and on behalf of
Xtrackers (IE) plc
Contact information
Xtrackers (IE) plc
78 Sir John Rogerson’s Quay, Dublin 2, Ireland
DWS Investment S.A.
2, boulevard Konrad Adenauer, L-1115 Luxembourg, Grand Duchy of Luxembourg
Registered in Dublin, Ireland as an open-ended variable capital umbrella investment company with limited liability and as an umbrella fund with segregated liability between funds.
Registration Number 393802. Registered Office as above.
Directors: Tom Murray (Irish), Michael Whelan (Irish), Gerry Grimes (Irish), Julien Boulliat (French), Philippe Ah-Sun (British) and Roberto Cesca (Italian).
View source version on businesswire.com: https://www.businesswire.com/news/home/20250103786928/en/
Latest directors dealings
- 2 hours ago Frasers Group
- 2 hours ago Cavendish Financial
- 2 hours ago Diaceutics
- 2 hours ago AB Dynamics
- 15 hours ago Johnson Matthey